Seek truth from facts, competitive symbiosis
04
2026-04
On the afternoon of April 16, to comprehensively review the first-quarter business performance, systematically advance the implementation of the Amoeba Management model, and build a shared understanding of operational excellence across the organization, the Zhengqing Group’s First-Quarter Amoeba Promotion Conference was held at the Group’s headquarters in Huaihua. Wu Feichi, Chairman and President of the Group, along with the senior management team, attended the meeting, which was chaired by Rotating President Long Xianjun.
04
2026-04
On April 10, the inaugural Chinese Medicine Agriculture Expo and Chinese Medicine Agriculture Industry Conference opened with great fanfare at the Hunan International Convention and Exhibition Center (Mango Pavilion). During the morning’s keynote address, Academician Liu Liang of the Chinese Academy of Engineering—distinguished professor emeritus at Guangzhou University of Traditional Chinese Medicine and director of the National Key Laboratory of TCM Syndromes—delivered a speech. Drawing on examples such as artemisinin and Tamiflu, he underscored the original scientific and technological value of traditional Chinese medicine and highlighted the collaborative achievements with the Zhengqing Group. He stated that the qingteng alkaloid formulation “Zhengqing Fengtongning” has already met world-class pharmaceutical standards and that, going forward, the company will continue to pursue sincere, integrated cooperation among industry, academia, research, and clinical practice, firmly grasping the “one vine” to build a high‑tech industrial chain and drive the transformation of Chinese medicine agriculture from a resource‑based model to a technology‑driven one.
04
2026-04
The Zhengqing Mountain Honeysuckle GAP Base is jointly established by Hunan Zhengsheng Shan Yin Hua Agricultural Science and Technology Co., Ltd., a holding subsidiary of the Zhengqing Group, and China Resources Sanjiu Lianhe. The base adopts a pioneering integrated industrial‑chain model that encompasses seedling and breeding, cultivation, procurement, processing, and marketing of mountain honeysuckle, and has developed a standardized planting base spanning over 1,500 mu in Longtan Town, Xupu County. The successful completion of the extended Good Agricultural Practices (GAP) inspection for Chinese medicinal materials marks the official establishment of Hunan Province’s first—and China’s very first—mountain honeysuckle GAP base in Huaihua. In addition, the Zhengqing Group is constructing a mountain honeysuckle distribution and trading center in Xupu, with storage capacity exceeding 2,000 tons, which is slated to be completed and put into operation soon.
04
2026-04
On March 31, the unveiling ceremony for the demonstration site of Academician Liu Liang’s team’s “Thousand Counties, Ten Thousand Towns” initiative, along with a training session for the Zhuxi County Acupuncture and Rehabilitation Quality Control Center, was held at the Zhuxi County Traditional Chinese Medicine Hospital, presided over by Chen Shengming, Party Secretary of the County Health Commission. Zhuxi County has become Hubei Province’s first demonstration site under this program. As an important grassroots implementation of the academician‑led project, the establishment of this demonstration site represents a pivotal step for Zhuxi County in advancing the high‑quality development of TCM, addressing shortcomings in primary‑level medical services, and improving public health. It also marks a significant milestone in bridging cutting‑edge scientific research with frontline healthcare, thereby bolstering rural revitalization through targeted medical support.
03
2026-03
To further promote the integration of high-quality traditional Chinese medicine resources into grassroots healthcare settings and enhance the standardized diagnosis and treatment of rheumatic and pain-related conditions at primary-level medical institutions, the kick-off meeting for the demonstration site under Liu Liang’s “Academician Project to the Grassroots—Thousand Counties, Ten Thousand Towns Initiative,” along with a training workshop on the promotion of appropriate TCM techniques organized by the Wulong District Medical Association, was successfully held at the Wulong District Traditional Chinese Medicine Hospital from March 27 to 28, 2026. The event was hosted by the Wulong District Health Commission and co-organized by the Wulong District TCM Hospital and the Wulong District Medical Association.
03
2026-03
With the arrival of spring in March, another milestone has been achieved in making healthcare more accessible to the people. On March 16, a grand unveiling and signing ceremony for the demonstration site of Academician Liu Liang’s Expert Workstation—under the “Academician Project Goes to the Grassroots: Thousand Counties, Ten Thousand Towns Initiative”—was held at the Guangxin District People’s Hospital. As an integral part of this initiative, a training course on the “Rheumatism and Pain Triple Sequential Therapy” also commenced from March 15 to 17, marking the official introduction of this nationally recognized, high‑quality diagnostic and treatment technique for rheumatic and painful conditions to Guangxin. Residents across the district can now access standardized care led by an academician‑level team right at their doorstep, injecting strong momentum into the district’s efforts to enhance its capacity for the prevention and management of rheumatic and pain‑related diseases.
03
2026-03
Spring breezes bring warmth, and good news keeps pouring in! In March 2026, Zhengqing Haiqin (Zhuhai Hengqin) Technology Co., Ltd. reached a pivotal moment in its corporate development: the company officially obtained Certificate B of the Drug Production License issued by the Guangdong Provincial Drug Administration. This is more than just a certificate—it marks an important milestone on Zhengqing Haiqin’s path toward high‑quality growth, signifying that we have now acquired the qualifications of a Marketing Authorization Holder (MAH). With this, we possess robust capabilities spanning from R&D to industrialization, and from domestic expansion to international outreach. This recognition underscores the authority of our R&D prowess and compliance framework, while also bolstering our confidence as we accelerate the modernization and globalization of traditional Chinese medicine.
03
2026-03
Recently, our company has achieved a major breakthrough in pharmaceutical R&D and registration: four drug products have successfully obtained production registration approvals from the National Medical Products Administration, and one product has received clinical trial approval. These accomplishments underscore the company’s strength and sustained innovation capacity in the field of drug development, injecting strong momentum into the enterprise’s high-quality growth.
03
2026-03
On February 28, the city held a grand conference to promote the robust development of the private sector and advance the “Year of Enterprise Services” initiative. At the event, Hunan Zhengqing Pharmaceutical Group Co., Ltd. was publicly commended as one of Huaihua City’s “Top Ten Tax‑Paying Enterprises.” Wu Feichi, Chairman and President of Zhengqing Group, was invited to deliver a keynote address on behalf of the city’s “Top Ten Tax‑Paying Enterprises,” key enterprises in the traditional Chinese medicine industry chain, and outstanding private entrepreneurs recognized with the New Hunan Contribution Award, sharing his company’s experience and practical achievements.
Copyright Hunan Zhengqing Pharmaceutical Group Co., Ltd.
Virtual Showroom：
Agent：
OA：
CRM：
在线客服添加返回顶部
右侧在线客服样式 1,2,3 1
图片alt标题设置： Hunan Zhengqing Pharmaceutical Group Co., Ltd.
表单验证提示文本： Please enter correct content!
循环体没有内容时： Updating......
CSS / JS 文件放置地